Filing summary
Entity note: The supplied filing is Tempur-Pedic International Inc.’s Form 10-Q, not a filing bearing the name SOMNIGROUP INTERNATIONAL INC. The summary below reflects the filing provided.
Business context and reporting period
Unaudited results cover the three months ended March 31, 2012, compared with the first quarter of 2011. Tempur-Pedic manufactures and sells premium mattresses, pillows, and related products through Retail, Direct, Healthcare, and third-party channels in approximately 80 countries. It reports North America and International segments.
Financial performance and liquidity
Unless stated otherwise, amounts are in millions of dollars. Revenue grew 18.0% to $384.4; gross profit increased 20.9% to $206.0. Net income rose 16.5% to $56.2, while diluted EPS increased to $0.86 from $0.68. Lower weighted-average shares contributed to EPS growth.
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Gross margin | 53.6% | 52.3% |
| Operating income / margin | $86.1 / 22.4% | $75.3 / 23.1% |
| Net income / margin | $56.2 / 14.6% | $48.3 / 14.8% |
| Operating cash flow | $44.6 | $55.7 |
| Capital expenditures | $6.6 | $5.2 |
North America sales increased 17.5% to $269.0; International sales grew 19.2% to $115.4 (21.8% on a constant-currency basis). Gross margin improved in North America, to 51.0% from 48.8%, but declined internationally, to 59.6% from 60.4%.
At March 31, cash was $134.0, working capital was $259.3, and long-term debt was $565.0, down $20.0 from year-end. Revolver availability was approximately $204.0, including the effect of letters of credit. The company reported compliance with debt covenants; funded debt to EBITDA was 1.40x against a maximum of 3.0x. Operating cash flow fell year over year, mainly due to working-capital changes. Cash and cash equivalents increased $22.6 during the quarter.
Material changes and management commentary
- Management attributed sales growth chiefly to marketing investment, new products, and broader distribution. Retail remained the largest channel; Direct sales rose 33.1%.
- Selling and marketing expenses increased 29.4% to $83.3; advertising rose 36.9% to $47.2. Higher marketing spending reduced operating margin despite improved gross margin.
- Management expected 2012 capital expenditures of approximately $50.0, including information technology investments and a new Lexington headquarters. Capital commitments for the headquarters were approximately $14.2 at quarter-end.
- Management expected full-year 2012 gross margin to increase, supported by productivity and volume leverage, partly offset by higher commodity costs. It also cited continuing economic uncertainty and modestly unfavorable currency assumptions.
- On April 2, 2012, the company acquired its Polish distributor for approximately $2.0 in cash, with potential additional payments tied to operating targets.
- The company repurchased approximately 168,500 shares for $12.3 during the quarter and authorized a new $250.0 million repurchase program in January; $237.7 remained at March 31.
Risks, contingencies, and unusual items
- A Danish tax dispute concerning intercompany royalties involves assessments of approximately $103.1, including interest and penalties. The proceedings were on hold pending a bilateral pricing agreement; the company disputed the assessments and said the possible change in unrecognized tax benefits could not be estimated.
- Related litigation includes a U.S. antitrust class action and a New York Attorney General action concerning the company’s retail pricing policy. The company considered losses remote based on its assessment, but outcomes remained uncertain.
- Debt is predominantly variable-rate. After hedging, approximately $315.0 remained variable-rate; a 100-basis-point rate increase was estimated to reduce next-year pretax income by approximately $3.2.
- Other principal risks include economic weakness, competition and price promotion, raw-material inflation, foreign-exchange movements, and the ability to sustain growth and margins. Management stated that cash from operations and facility availability should meet foreseeable needs, but gave no assurance of future cash generation or borrowing availability.
Most important facts for investors to verify
- Confirm the filing’s registrant identity and reporting period; the provided filing identifies Tempur-Pedic International Inc.
- Track whether sales growth and gross-margin gains persist as advertising costs and commodity prices change.
- Monitor operating cash conversion, working capital, planned capital spending, debt paydown, and share repurchases.
- Review developments in the Danish tax assessments and the pending pricing-related litigation.
- Assess the effect of currency and interest-rate changes, including the coverage and terms of the company’s hedges.